Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Supernus Pharmaceuticals
Business Segments
Business Segments
R&D
R&D
Supernus Pharmaceuticals
·
Business Segments
·
1 segment
·
Rolls up to
R&D
Breakdown
Segments
Business Segments
View metric
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Business Segments
$26.93M
$22.12M
$29.37M
$27.83M
$39.44M
Total
$26.93M
$22.12M
$29.37M
$27.83M
$39.44M